{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:00:42Z","timestamp":1792666842993,"version":"4.5.0"},"reference-count":51,"publisher":"BMJ","issue":"23","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2020,7,28]]},"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:p>Heart failure with preserved ejection fraction (HFpEF) affects half of all patients with heart failure. While previously neglected, the right ventricle (RV) has sparked interest in recent years as a means for better understanding this condition and as a potential therapeutic target.<\/jats:p>\n               <jats:p>Right ventricular dysfunction (RVD) is present in 4%\u201350% of patients with HFpEF. The RV is intimately connected to the pulmonary circulation, and pulmonary hypertension is commonly implicated in the pathophysiology of RVD. The development of RVD in HFpEF may also be driven by comorbidities, such as chronic obstructive pulmonary disease, obesity, obstructive sleep apnoea and atrial fibrillation. The evaluation of RVD is particularly challenging due to anatomical and structural factors, as well as unique physiological characteristics of this chamber like load and interventricular dependency. Fractional area change, tricuspid annular plane systolic excursion and tricuspid annular systolic velocity are commonly used measurements of RV function. Speckle tracking echocardiography and cardiac magnetic resonance (CMR) are also gaining attention as important tools for the assessment of RV structure, fibre deformation and systolic performance. Further research is needed to confirm the utility and prognostic significance of RV [<jats:sup>18<\/jats:sup>F]fluorodeoxyglucose (FDG) positron emission tomography imaging as FDG accumulation is suggested to increase with progressive RVD. Targeted pharmacotherapy with phosphodiesterase inhibitors, guanylate\u2013cyclase stimulators, nitrates and inhaled inorganic nitrites have yet to demonstrate improvement in RVD, compelling the need for evaluation and discovery of novel pharmacological interventions for this entity.<\/jats:p>","DOI":"10.1136\/heartjnl-2020-317342","type":"journal-article","created":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T17:30:43Z","timestamp":1599499843000},"page":"1798-1804","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":37,"title":["Right ventricle in heart failure with preserved ejection fraction"],"prefix":"10.1136","volume":"106","author":[{"given":"Felix","family":"Berglund","sequence":"first","affiliation":[{"name":"Cardiology, S\u00f6dersjukhuset Anestesi Intensivv\u00e5rdsverksamheten, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5404-4389","authenticated-orcid":false,"given":"Pamela","family":"Pi\u00f1a","sequence":"additional","affiliation":[{"name":"Cardiology, CEDIMAT Cardiovascular Center, Santo Domingo, Dominican Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar J","family":"Herrera","sequence":"additional","affiliation":[{"name":"Cardiology, CEDIMAT Cardiovascular Center, Santo Domingo, Dominican Republic"},{"name":"Cardiology, Montefiore Center for Heart and Vascular Care, Albert Einstein College of Medicine, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,9,7]]},"reference":[{"key":"2025092007004639000_106.23.1798.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0805450"},{"key":"2025092007004639000_106.23.1798.2","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1093\/eurheartj\/ehy005","article-title":"Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study","volume":"39","author":"Lam","year":"2018","journal-title":"Eur Heart J"},{"key":"2025092007004639000_106.23.1798.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1313731"},{"key":"2025092007004639000_106.23.1798.4","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/ejhf.630","article-title":"Right ventricular dysfunction in heart failure with preserved ejection fraction: a systematic review and meta-analysis","volume":"18","author":"Gorter","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2025092007004639000_106.23.1798.5","doi-asserted-by":"publisher","DOI":"10.1093\/ejechocard\/jep052"},{"key":"2025092007004639000_106.23.1798.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2011.04.005"},{"key":"2025092007004639000_106.23.1798.7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.114.001583"},{"key":"2025092007004639000_106.23.1798.8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu193"},{"key":"2025092007004639000_106.23.1798.9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.008461"},{"key":"2025092007004639000_106.23.1798.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2018.12.035"},{"key":"2025092007004639000_106.23.1798.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2014.05.044"},{"key":"2025092007004639000_106.23.1798.12","first-page":"73","article-title":"The right ventricle: biologic insights and response to disease: updated","volume":"9","author":"Walker","year":"2013","journal-title":"Curr Cardiol Rev"},{"key":"2025092007004639000_106.23.1798.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02048-X"},{"key":"2025092007004639000_106.23.1798.14","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jamacardio.2018.0128","article-title":"Association between hemodynamic markers of pulmonary hypertension and outcomes in heart failure with preserved ejection fraction","volume":"3","author":"Vanderpool","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2025092007004639000_106.23.1798.15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.113.000823"},{"key":"2025092007004639000_106.23.1798.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.11.051"},{"key":"2025092007004639000_106.23.1798.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2020.01.008"},{"key":"2025092007004639000_106.23.1798.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.10.047"},{"key":"2025092007004639000_106.23.1798.19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.032207"},{"key":"2025092007004639000_106.23.1798.20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/ejhf.1029","article-title":"Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. position statement on behalf of the heart failure association of the European Society of cardiology","volume":"20","author":"Gorter","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2025092007004639000_106.23.1798.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2018.05.022"},{"key":"2025092007004639000_106.23.1798.22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.674028"},{"key":"2025092007004639000_106.23.1798.23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijcard.2018.04.001","article-title":"Non-Cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction","volume":"271","author":"Streng","year":"2018","journal-title":"Int J Cardiol"},{"key":"2025092007004639000_106.23.1798.24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cardfail.2017.11.005","article-title":"Right heart dysfunction in heart failure with preserved ejection fraction: the impact of atrial fibrillation","volume":"24","author":"Gorter","year":"2018","journal-title":"J Card Fail"},{"key":"2025092007004639000_106.23.1798.25","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv338"},{"key":"2025092007004639000_106.23.1798.26","doi-asserted-by":"crossref","first-page":"3293.2","DOI":"10.1093\/eurheartj\/ehw241","article-title":"Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction","volume":"37","author":"Borlaug","year":"2016","journal-title":"Eur Heart J"},{"key":"2025092007004639000_106.23.1798.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2014.10.003"},{"key":"2025092007004639000_106.23.1798.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2010.05.010"},{"key":"2025092007004639000_106.23.1798.29","doi-asserted-by":"crossref","unstructured":"Agoston-Coldea L , Lupu S . Right chambers quantification in clinical practice: echocardiography compared with cardiac magnetic resonance imaging. Hot Top Echocardiogr. Published online 2013.","DOI":"10.5772\/55832"},{"key":"2025092007004639000_106.23.1798.30","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jew011"},{"key":"2025092007004639000_106.23.1798.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2010.05.010"},{"key":"2025092007004639000_106.23.1798.32","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.418"},{"key":"2025092007004639000_106.23.1798.33","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/HCO.0000000000000315","article-title":"Right heart imaging in patients with heart failure: a tale of two ventricles","volume":"31","author":"Amsallem","year":"2016","journal-title":"Curr Opin Cardiol"},{"key":"2025092007004639000_106.23.1798.34","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1007\/s00330-019-06228-2","article-title":"CT compared to MRI for functional evaluation of the right ventricle: a systematic review and meta-analysis","volume":"29","author":"Fu","year":"2019","journal-title":"Eur Radiol"},{"key":"2025092007004639000_106.23.1798.35","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.076075"},{"key":"2025092007004639000_106.23.1798.36","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01913-2018"},{"key":"2025092007004639000_106.23.1798.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2012.10.009"},{"key":"2025092007004639000_106.23.1798.38","first-page":"161","article-title":"Right heart failure: a hemodynamic review","volume":"38","author":"El Hajj","year":"2020","journal-title":"Cardiol Clin"},{"key":"2025092007004639000_106.23.1798.39","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.655266"},{"key":"2025092007004639000_106.23.1798.40","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.2024"},{"key":"2025092007004639000_106.23.1798.41","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-0106"},{"key":"2025092007004639000_106.23.1798.42","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/eurheartj\/ehw593","article-title":"Vericiguat in patientS with worsening chronic heart failurE and preserved ejection fraction: results of the soluble guanylate cyclase stimulatoR in heart failurE patientS with preserved EF (SOCRATES-PRESERVED) study","volume":"38","author":"Pieske","year":"2017","journal-title":"Eur Heart J"},{"key":"2025092007004639000_106.23.1798.43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1510774"},{"key":"2025092007004639000_106.23.1798.44","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1001\/jama.2018.14852","article-title":"Effect of inorganic nitrite vs placebo on exercise capacity among patients with heart failure with preserved ejection fraction: the INDIE-HFpEF randomized clinical trial","volume":"320","author":"Borlaug","year":"2018","journal-title":"JAMA"},{"key":"2025092007004639000_106.23.1798.45","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11897-015-0267-3","article-title":"Epidemiology of right ventricular dysfunction in heart failure with preserved ejection fraction","volume":"12","author":"Zakeri","year":"2015","journal-title":"Curr Heart Fail Rep"},{"key":"2025092007004639000_106.23.1798.46","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.008461"},{"key":"2025092007004639000_106.23.1798.47","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00157.2013"},{"key":"2025092007004639000_106.23.1798.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2016.12.024"},{"key":"2025092007004639000_106.23.1798.49","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002729","article-title":"Impaired right Ventricular\u2013Pulmonary arterial coupling and effect of sildenafil in heart failure with preserved ejection fraction","volume":"9","author":"Imad","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2025092007004639000_106.23.1798.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2011.12.003"},{"key":"2025092007004639000_106.23.1798.51","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.113.000854"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2020-317342","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T14:00:53Z","timestamp":1758376853000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2020-317342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,7]]},"references-count":51,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2020,11,13]]},"published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10.1136\/heartjnl-2020-317342"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2020-317342","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,7]]}}}